Cyramza contains Ramucirumab, 100mg/10mL, 500mg/50mL, supplied as injection. Manufacturer: Eli Lilly. Therapeutic class: VEGFR-2 mAb.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.